Education
About Us
Working with TipRanks
Follow Us
Athira Pharma (ATHA)
NASDAQ:ATHA
Total Valuation
Athira Pharma has a market cap or net worth of $15.26M. The enterprise value is -$17.00M.
Market Cap$15.26M
Enterprise Value-$17.00M
Share Statistics
Athira Pharma has 3,943,887 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,943,887
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Athira Pharma’s return on equity (ROE) is -2.16 and return on invested capital (ROIC) is -219.08%.
Return on Equity (ROE)-2.16
Return on Assets (ROA)-1.65
Return on Invested Capital (ROIC)-219.08%
Return on Capital Employed (ROCE)-2.21
Revenue Per Employee0.00
Profits Per Employee-3.73M
Employee Count26
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Athira Pharma is ―. Athira Pharma’s PEG ratio is 0.01.
PE Ratio―
PS Ratio0.00
PB Ratio0.50
Price to Fair Value0.50
Price to FCF-0.23
Price to Operating Cash Flow-0.33
PEG Ratio0.01
Income Statement
In the last 12 months, Athira Pharma had revenue of 0.00 and earned -96.94M in profits. Earnings per share was -25.20.
Revenue0.00
Gross Profit0.00
Operating Income-100.90M
Pretax Income-96.94M
Net Income-96.94M
EBITDA-95.81M
Earnings Per Share (EPS)-25.20
Cash Flow
In the last 12 months, operating cash flow was -52.34M and capital expenditures 0.00, giving a free cash flow of -52.34M billion.
Operating Cash Flow-52.34M
Free Cash Flow-52.34M
Free Cash Flow per Share-13.27
Dividends & Yields
Athira Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.30
52-Week Price Change-32.93%
50-Day Moving Average4.15
200-Day Moving Average3.58
Relative Strength Index (RSI)39.56
Average Volume (3m)41.47K
Important Dates
Athira Pharma upcoming earnings date is Mar 19, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date―
Financial Position
Athira Pharma as a current ratio of 4.18, with Debt / Equity ratio of 3.40%
Current Ratio4.18
Quick Ratio4.18
Debt to Market Cap0.02
Net Debt to EBITDA0.49
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Athira Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Athira Pharma EV to EBITDA ratio is 0.26, with an EV/FCF ratio of 0.25.
EV to Sales0.00
EV to EBITDA0.26
EV to Free Cash Flow0.25
EV to Operating Cash Flow0.25
Balance Sheet
Athira Pharma has $25.23M in cash and marketable securities with $912.00K in debt, giving a net cash position of $24.31M billion.
Cash & Marketable Securities$25.23M
Total Debt$912.00K
Net Cash$24.31M
Net Cash Per Share$6.16
Tangible Book Value Per Share$11.65
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Athira Pharma is $4.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.00
Price Target Upside3.36% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast66.10%